| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.29B | 13.39B | 13.73B | 14.64B | 18.36B | 16.09B |
| Gross Profit | 2.47B | 2.49B | 2.57B | 2.49B | 2.66B | 2.34B |
| EBITDA | 681.00M | 788.00M | 952.00M | 978.00M | 929.00M | 884.00M |
| Net Income | 390.00M | 397.00M | 435.00M | 512.00M | 438.00M | 358.00M |
Balance Sheet | ||||||
| Total Assets | 13.12B | 13.04B | 12.81B | 13.18B | 12.78B | 12.79B |
| Cash, Cash Equivalents and Short-Term Investments | 2.11B | 1.70B | 1.98B | 2.04B | 1.78B | 1.96B |
| Total Debt | 6.03B | 4.83B | 5.26B | 5.90B | 6.47B | 7.00B |
| Total Liabilities | 8.48B | 7.39B | 7.96B | 8.57B | 8.99B | 9.33B |
| Stockholders Equity | 4.64B | 5.65B | 4.85B | 4.61B | 3.79B | 3.46B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 156.00M | 759.00M | 897.00M | 454.00M | -452.00M |
| Operating Cash Flow | 0.00 | 521.00M | 877.00M | 908.00M | 775.00M | 633.00M |
| Investing Cash Flow | 0.00 | -229.00M | -153.00M | 74.00M | -302.00M | -1.06B |
| Financing Cash Flow | 0.00 | -568.00M | -788.00M | -737.00M | -658.00M | 379.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥5.61B | 5.39 | ― | 3.02% | 8.78% | 31.99% | |
65 Neutral | ¥21.57B | 6.04 | ― | 1.29% | 1.42% | 88.77% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥4.70B | 12.74 | ― | 2.93% | -2.46% | -9.16% | |
58 Neutral | ¥2.19B | 6.18 | ― | 3.32% | -1.20% | 35.34% | |
57 Neutral | ¥16.64B | 20.95 | ― | 1.38% | 8.18% | 40.68% | |
54 Neutral | ¥11.30B | 15.72 | ― | 1.87% | 1.90% | 24.92% |